Enveric Biosciences, Inc. (NASDAQ: ENVB) reported Q3 EPS of ($0.24), $0.28 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Enveric Biosciences, Inc. (ENVB) click here.